Israel names coronavirus vaccine candidate Brilife
The Israel Institute for Biological Research has named its COVID-19 vaccine candidate Brilife, with Phase 1 human trials scheduled to begin at the end of October 2020 at two medical centres in Jerusalem and Tel Hashomer.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
NewsIsrael names coronavirus vaccine candidate Brilife
Sign in or subscribeBrowse free archive reportsThe Israel Institute for Biological Research has named its COVID-19 vaccine candidate Brilife, with Phase 1 human trials scheduled to begin at the end of October 2020 at two medical centres in Jerusalem and Tel Hashomer.